Clinical Dynamix
The Vice President of Regulatory Affairs will lead the development and execution of global regulatory strategies for a stem cell therapeutic company, guiding submissions to FDA, EMA, and other health authorities. This senior leader will build in‑house regulatory capabilities, manage budgets and vendors, and serve as the primary liaison for regulatory compliance and interactions with authorities.
Clinical Dynamix matches exceptional talent with cutting-edge companies focused in: Pharmaceutical, Biotechnology, Medical Device/Diagnostics & Gene Therapy
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Clinical Dynamix.
Clinical Dynamix didn’t post a salary, so this is our estimate from similar listings.
11% below the average for this role